— Know what they know.
Not Investment Advice
Also trades as: SUMICHEM.BO (BSE) · $vol 0M

SUMICHEM.NS NSE

Sumitomo Chemical India Limited
1W: -7.1% 1M: -18.8% 3M: -16.9% YTD: -1.2% 1Y: -30.1% 3Y: +2.3% 5Y: +0.4%
₹420.25 ($4.36)
-13.00 (-3.00%)
 
NSE · Basic Materials · Agricultural Inputs · Tech Score Sell · Power 30 · ₹209.8B mcap · 122M float · 0.671% daily turnover

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
Oct 01, 2026
DCF
5
ROE
1
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. SUMICHEM.NS receives an overall rating of C. Strongest factors: DCF (5/5). Areas of concern: ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-07-29 A- C
2026-06-03 B+ A-
2026-05-29 C B+
2026-01-28 A- C

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 70 Grade A
Profitability
59
Balance Sheet
98
Earnings Quality
62
Growth
47
Value
51
Momentum
76
Safety
100
Cash Flow
89
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. SUMICHEM.NS scores highest in Safety (100/100) and lowest in Growth (47/100). An overall grade of A places SUMICHEM.NS among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
12.13
Safe Zone
Piotroski F-Score
5/9
✓ ✓ ✓ ✓ ✗ ✓ ✗ ✗ ✗
Beneish M-Score
-2.27
Unlikely Manipulator
Ohlson O-Score
-12.28
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AAA
Score: 96.6/100
Trend: Stable
Earnings Quality
75/100
OCF/NI: 1.52x
Accruals: -6.7%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. SUMICHEM.NS scores 12.13, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. SUMICHEM.NS scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. SUMICHEM.NS's score of -2.27 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. SUMICHEM.NS's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. SUMICHEM.NS receives an estimated rating of AAA (score: 96.6/100), with a stable trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). SUMICHEM.NS's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
36.20x
PEG
8.98x
P/S
6.46x
P/B
6.19x
P/FCF
23.22x
P/OCF
22.06x
EV/EBITDA
22.74x
EV/Revenue
5.32x
EV/EBIT
24.74x
EV/FCF
22.01x
Earnings Yield
2.99%
FCF Yield
4.31%
Shareholder Yield
0.53%
Graham Number
$129.01
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 36.2x earnings, SUMICHEM.NS commands a growth premium. Graham's intrinsic value formula yields $129.01 per share, 226% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.746
NI / EBT
×
Interest Burden
1.044
EBT / EBIT
×
EBIT Margin
0.215
EBIT / Rev
×
Asset Turnover
0.767
Rev / Assets
×
Equity Multiplier
1.341
Assets / Equity
=
ROE
17.3%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. SUMICHEM.NS's ROE of 17.3% is driven by Asset Turnover (0.767), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
2.54%
Fair P/E
13.58x
Intrinsic Value
$147.88
Price/Value
2.46x
Margin of Safety
-146.45%
Premium
146.45%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with SUMICHEM.NS's realized 2.5% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. SUMICHEM.NS trades at a 146% premium to its adjusted intrinsic value of $147.88, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 13.6x compares to the current market P/E of 36.2x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1635 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$417.60
Median 1Y
$439.07
5th Pctile
$238.18
95th Pctile
$812.43
Ann. Volatility
36.6%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
ROE 26.9% 23.1% 25.3% 24.4% 26.3% 25.3% 25.4% 23.3% 19.8% 15.5% 14.0% 15.3% 18.0% 18.5% 19.7% 18.9% 20.9% 18.4% 18.0% 17.3% 17.26%
ROA 15.6% 13.0% 14.2% 14.9% 16.1% 15.6% 15.6% 15.7% 13.3% 10.5% 9.5% 11.1% 13.0% 13.1% 14.0% 13.9% 15.3% 13.1% 12.8% 12.9% 12.87%
ROIC 58.1% 59.8% 63.4% 47.1% 50.9% 49.4% 49.5% 39.5% 34.2% 49.7% 46.1% 35.2% 39.7% 47.8% 50.2% 41.9% 45.0% 30.6% 26.4% 22.4% 22.37%
ROCE 29.8% 25.8% 28.5% 28.0% 29.9% 28.9% 28.6% 25.2% 20.8% 16.1% 13.8% 16.4% 19.6% 19.6% 21.0% 18.9% 20.8% 19.2% 19.7% 19.9% 19.88%
Gross Margin 36.1% 39.0% 37.6% 35.3% 35.1% 37.9% 35.3% 28.6% 31.1% 38.4% 39.8% 38.7% 38.9% 42.6% 42.1% 37.2% 38.1% 33.8% 32.9% 29.8% 29.83%
Operating Margin 29.2% 34.0% 30.2% 21.0% 29.3% 33.0% 28.4% 12.2% 22.8% 31.8% 29.8% 21.1% 31.1% 35.9% 31.5% 19.9% 31.4% 21.6% 14.6% 17.1% 17.15%
Net Margin 13.5% 16.9% 12.6% 11.3% 14.0% 18.0% 12.0% 11.1% 8.5% 15.9% 10.1% 16.3% 15.1% 19.5% 13.5% 14.7% 16.9% 19.1% 13.3% 16.3% 16.27%
EBITDA Margin 18.7% 23.6% 17.4% 15.9% 18.5% 24.6% 15.3% 11.5% 10.4% 20.7% 10.7% 19.8% 18.7% 24.8% 15.2% 16.8% 20.3% 27.6% 21.2% 24.3% 24.33%
FCF Margin 10.2% 11.9% 13.0% 10.2% 7.5% 5.2% 3.0% 3.1% 3.3% 3.6% 4.2% 9.3% 13.9% 18.1% 22.1% 20.4% 17.5% 25.3% 24.3% 24.2% 24.18%
OCF Margin 11.6% 13.4% 14.5% 12.2% 9.9% 7.1% 4.7% 3.9% 3.3% 3.6% 4.2% 9.8% 15.0% 19.7% 24.1% 22.1% 18.9% 26.7% 25.4% 25.4% 25.44%
ROE 3Y Avg snapshot only 16.19%
ROE 5Y Avg snapshot only 18.33%
ROA 3Y Avg snapshot only 12.01%
ROIC 3Y Avg snapshot only 20.19%
ROIC Economic snapshot only 16.14%
Cash ROA snapshot only 18.42%
Cash ROIC snapshot only 33.70%
CROIC snapshot only 32.02%
NOPAT Margin snapshot only 16.89%
Pretax Margin snapshot only 22.47%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 11.57%
SBC / Revenue snapshot only 0.00%
Valuation
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
P/E Ratio 50.61 53.33 46.82 51.55 45.38 48.86 47.39 41.37 49.96 56.44 59.52 46.75 54.88 57.41 51.52 54.98 47.39 49.05 44.25 33.48 36.197
P/S Ratio 6.77 7.04 6.43 7.13 6.34 7.07 6.79 5.92 6.55 6.85 7.01 6.07 8.06 9.12 8.45 8.83 7.84 8.05 7.27 5.61 6.465
P/B Ratio 12.20 11.15 10.71 11.33 10.73 11.08 10.78 8.72 8.93 8.22 7.82 7.08 9.77 10.23 9.79 9.58 9.10 8.32 7.35 5.36 6.188
P/FCF 66.52 59.05 49.36 69.61 84.37 136.51 222.88 191.78 196.38 189.63 166.16 65.39 58.10 50.25 38.31 43.30 44.73 31.80 29.94 23.22 23.216
P/OCF 58.16 52.43 44.34 58.30 63.93 99.26 145.79 151.97 196.38 189.63 166.16 61.67 53.91 46.25 35.09 39.88 41.46 30.15 28.58 22.06 22.061
EV/EBITDA 36.07 37.48 32.78 36.14 32.21 34.78 34.18 31.20 38.31 42.85 46.59 36.20 42.99 44.64 39.97 43.39 37.57 37.42 31.80 22.74 22.740
EV/Revenue 6.59 6.77 6.18 6.96 6.17 6.87 6.59 5.77 6.38 6.39 6.52 5.77 7.77 8.69 8.04 8.44 7.48 7.72 6.94 5.32 5.322
EV/EBIT 38.59 40.13 34.92 38.26 33.91 36.57 35.89 32.93 41.02 46.69 51.68 39.80 46.77 48.20 43.11 46.97 40.42 40.30 34.50 24.74 24.740
EV/FCF 64.75 56.79 47.40 67.89 82.18 132.66 216.43 186.89 191.49 177.04 154.57 62.13 56.00 47.91 36.45 41.42 42.68 30.52 28.57 22.01 22.010
Earnings Yield 2.0% 1.9% 2.1% 1.9% 2.2% 2.0% 2.1% 2.4% 2.0% 1.8% 1.7% 2.1% 1.8% 1.7% 1.9% 1.8% 2.1% 2.0% 2.3% 3.0% 2.99%
FCF Yield 1.5% 1.7% 2.0% 1.4% 1.2% 0.7% 0.4% 0.5% 0.5% 0.5% 0.6% 1.5% 1.7% 2.0% 2.6% 2.3% 2.2% 3.1% 3.3% 4.3% 4.31%
PEG Ratio snapshot only 8.977
Price/Tangible Book snapshot only 5.501
EV/OCF snapshot only 20.915
EV/Gross Profit snapshot only 15.560
Acquirers Multiple snapshot only 23.517
Shareholder Yield snapshot only 0.53%
Graham Number snapshot only $129.01
Leverage & Solvency
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Current Ratio 2.14 2.17 2.17 2.47 2.47 2.40 2.40 2.99 2.99 3.11 3.11 3.34 3.34 2.98 2.98 3.13 3.13 3.12 3.12 3.44 3.444
Quick Ratio 1.44 1.62 1.62 1.55 1.55 1.71 1.71 2.03 2.03 2.52 2.52 2.58 2.58 2.44 2.44 2.40 2.40 2.58 2.58 2.65 2.654
Debt/Equity 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.02 0.02 0.02 0.02 0.019
Net Debt/Equity -0.32 -0.43 -0.43 -0.28 -0.28 -0.31 -0.31 -0.22 -0.22 -0.55 -0.55 -0.35 -0.35 -0.48 -0.48 -0.42 -0.42 -0.34 -0.34 -0.28 -0.279
Debt/Assets 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.014
Debt/EBITDA 0.06 0.09 0.08 0.06 0.06 0.05 0.05 0.05 0.06 0.06 0.07 0.07 0.06 0.05 0.05 0.08 0.08 0.09 0.08 0.08 0.084
Net Debt/EBITDA -0.98 -1.49 -1.36 -0.91 -0.86 -1.01 -1.02 -0.82 -0.98 -3.05 -3.49 -1.90 -1.61 -2.18 -2.05 -1.97 -1.80 -1.58 -1.52 -1.25 -1.246
Interest Coverage 77.81 73.26 79.29 63.96 72.54 86.39 89.13 113.99 93.35 78.52 68.53 80.75 99.06 111.12 106.40 96.60 98.47 86.32 85.83 89.02 89.023
Equity Multiplier 1.73 1.71 1.71 1.56 1.56 1.56 1.56 1.41 1.41 1.40 1.40 1.36 1.36 1.42 1.42 1.37 1.37 1.39 1.39 1.32 1.320
Cash Ratio snapshot only 1.039
Debt Service Coverage snapshot only 96.853
Cash to Debt snapshot only 15.922
FCF to Debt snapshot only 12.370
Defensive Interval snapshot only 2030.1 days
Efficiency & Turnover
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Asset Turnover 1.16 0.99 1.04 1.08 1.15 1.08 1.09 1.10 1.02 0.87 0.81 0.85 0.89 0.83 0.85 0.87 0.93 0.80 0.78 0.77 0.767
Inventory Turnover 2.60 3.07 3.23 2.28 2.44 3.00 3.07 2.50 2.35 2.91 2.68 2.40 2.41 3.23 3.31 2.86 3.07 3.51 3.53 2.90 2.899
Receivables Turnover 3.27 2.85 3.00 3.61 3.85 3.21 3.25 3.90 3.61 2.95 2.75 3.40 3.54 3.36 3.47 4.18 4.47 3.58 3.50 4.26 4.264
Payables Turnover 3.23 2.99 3.15 3.47 3.72 3.97 4.05 4.54 4.26 4.06 3.73 3.90 3.93 3.91 4.01 4.09 4.39 4.25 4.27 4.81 4.807
DSO 112 128 122 101 95 114 112 94 101 124 133 107 103 109 105 87 82 102 104 86 85.6 days
DIO 140 119 113 160 150 122 119 146 155 125 136 152 151 113 110 128 119 104 103 126 125.9 days
DPO 113 122 116 105 98 92 90 80 86 90 98 94 93 93 91 89 83 86 86 76 75.9 days
Cash Conversion Cycle 139 125 119 157 147 143 141 159 171 159 171 166 162 128 124 126 117 120 122 136 135.6 days
Fixed Asset Turnover snapshot only 6.335
Operating Cycle snapshot only 211.5 days
Cash Velocity snapshot only 3.213
Capital Intensity snapshot only 1.382
Growth (YoY)
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Revenue 1.5% 39.7% 14.8% 15.7% 17.5% 24.7% 20.1% 14.7% -0.5% -12.8% -19.9% -19.0% -9.0% 0.4% 11.5% 10.7% 13.8% 8.7% 2.9% 2.9% 2.85%
Net Income 2.6% 41.5% 28.2% 22.7% 22.7% 36.7% 25.3% 18.6% -6.6% -26.9% -34.2% -26.4% 2.1% 31.4% 55.3% 36.8% 28.2% 12.3% 3.0% 7.4% 7.41%
EPS 2.6% 41.6% 28.7% 23.4% 22.7% 36.8% 25.2% 18.6% -6.4% -27.1% -33.9% -26.6% 1.8% 31.5% 54.6% 37.0% 28.0% 12.3% 3.2% 7.2% 7.22%
FCF 2.1% 1.4% 1.1% 34.6% -13.3% -45.8% -71.9% -65.5% -55.8% -39.2% 10.8% 1.4% 2.8% 4.0% 4.8% 1.4% 43.8% 51.5% 13.3% 22.0% 21.99%
EBITDA 2.3% 34.5% 23.3% 23.7% 23.2% 36.4% 23.0% 10.1% -13.5% -34.2% -42.0% -30.1% -1.2% 31.1% 60.3% 35.2% 25.4% 15.2% 11.6% 23.7% 23.68%
Op. Income 2.6% 52.1% 23.9% 20.2% 20.1% 27.2% 19.4% 7.0% -12.8% -26.3% -31.5% -20.6% 2.8% 23.2% 38.3% 25.9% 20.0% -5.4% -21.8% -23.1% -23.07%
OCF Growth snapshot only 18.22%
Asset Growth snapshot only 12.86%
Equity Growth snapshot only 16.84%
Debt Growth snapshot only 21.98%
Shares Change snapshot only 0.17%
Dividend Growth snapshot only -60.30%
Growth (CAGR)
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Revenue 3Y — — — — — — — 99.0% 43.8% 15.0% 3.3% 2.4% 2.1% 3.0% 2.3% 0.9% 1.0% -1.6% -2.8% -2.7% -2.66%
Revenue 5Y — — — — — — — — — — — — — — — 47.8% 25.2% 10.6% 4.8% 4.1% 4.13%
EPS 3Y — — — — — — — 1.8% 61.1% 12.2% 2.1% 2.4% 5.4% 9.5% 8.6% 6.1% 6.8% 2.5% 1.8% 2.5% 2.54%
EPS 5Y — — — — — — — — — — — — — — — 85.7% 40.3% 15.9% 11.2% 9.6% 9.57%
Net Income 3Y — — — — — — — 1.8% 60.8% 12.2% 1.8% 2.3% 5.3% 9.5% 8.6% 6.1% 6.9% 2.5% 1.7% 2.6% 2.64%
Net Income 5Y — — — — — — — — — — — — — — — 85.7% 40.4% 15.8% 11.1% 9.5% 9.47%
EBITDA 3Y — — — — — — — 1.5% 51.5% 6.5% -4.2% -1.6% 1.7% 5.6% 4.6% 1.3% 2.3% -0.2% 1.3% 5.3% 5.31%
EBITDA 5Y — — — — — — — — — — — — — — — 72.0% 33.9% 12.8% 9.5% 9.7% 9.73%
Gross Profit 3Y — — — — — — — 1.1% 45.2% 12.5% 1.5% 2.5% 3.7% 6.1% 5.8% 3.8% 3.9% -0.8% -3.1% -3.3% -3.27%
Gross Profit 5Y — — — — — — — — — — — — — — — 56.6% 30.2% 11.5% 4.4% 2.6% 2.60%
Op. Income 3Y — — — — — — — 1.9% 56.3% 12.6% 0.4% 0.7% 2.5% 4.9% 4.2% 2.3% 2.5% -4.9% -9.5% -8.4% -8.39%
Op. Income 5Y — — — — — — — — — — — — — — — 88.1% 36.3% 10.7% 1.9% -0.2% -0.22%
FCF 3Y — — — — — — — 33.2% 5.7% -7.3% -13.5% 4.3% 13.2% 18.4% 22.0% 27.0% 34.0% 66.9% 94.1% 93.3% 93.34%
FCF 5Y — — — — — — — — — — — — — — — 69.5% 45.1% 43.5% 33.8% 27.4% 27.42%
OCF 3Y — — — — — — — 35.2% -0.7% -13.0% -18.7% 0.9% 11.0% 17.0% 21.2% 23.0% 25.3% 52.8% 71.1% 82.0% 81.98%
OCF 5Y — — — — — — — — — — — — — — — 66.0% 41.9% 39.7% 30.0% 24.8% 24.78%
Assets 3Y — — — — — — — 17.0% 17.0% 10.0% 10.0% 7.5% 7.5% 8.5% 8.5% 9.6% 9.6% 8.7% 8.7% 9.9% 9.92%
Assets 5Y — — — — — — — — — — — — — — — 13.5% 13.5% 10.9% 10.9% 10.9% 10.88%
Equity 3Y — — — — — — — 24.9% 24.9% 20.9% 20.9% 16.6% 16.6% 15.5% 15.5% 14.6% 14.6% 12.9% 12.9% 12.5% 12.48%
Book Value 3Y — — — — — — — 25.0% 25.1% 20.8% 21.2% 16.7% 16.6% 15.5% 15.5% 14.6% 14.5% 12.9% 13.0% 12.4% 12.38%
Dividend 3Y — — — — — — — -31.1% — — — 98.1% — — — 46.4% 4.5% -11.9% -33.1% -26.5% -26.53%
Growth Quality
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Revenue Stability — — — 0.87 0.91 1.00 0.98 0.83 0.76 0.62 0.19 0.13 0.08 0.02 0.00 0.60 0.65 0.51 0.26 0.23 0.232
Earnings Stability — — — 0.89 0.92 1.00 1.00 0.87 0.71 0.35 0.05 0.54 0.60 0.51 0.31 0.59 0.71 0.66 0.48 0.53 0.532
Margin Stability — — — 0.89 0.93 0.99 0.99 0.91 0.94 0.96 0.97 0.97 0.94 0.93 0.93 0.90 0.92 0.94 0.94 0.93 0.935
Rev. Growth Consistency 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence — — — 0.91 0.91 0.85 0.90 0.93 0.97 0.89 0.86 0.89 0.99 0.87 0.50 0.85 0.89 0.95 0.99 0.97 0.970
Earnings Smoothness 0.00 0.66 0.75 0.80 0.80 0.69 0.78 0.83 0.93 0.69 0.59 0.70 0.98 0.73 0.57 0.69 0.75 0.88 0.97 0.93 0.929
ROE Trend — — — 0.10 0.07 0.03 0.00 -0.01 -0.06 -0.07 -0.10 -0.06 -0.03 -0.01 0.01 -0.01 0.01 0.01 0.01 -0.00 -0.003
Gross Margin Trend — — — 0.04 0.02 0.00 -0.01 -0.02 -0.03 -0.03 -0.02 0.01 0.04 0.05 0.05 0.04 0.04 0.00 -0.02 -0.04 -0.044
FCF Margin Trend — — — 0.01 -0.02 -0.04 -0.07 -0.06 -0.06 -0.05 -0.04 0.03 0.08 0.14 0.18 0.14 0.09 0.14 0.11 0.09 0.093
Sustainable Growth Rate 25.0% 21.4% 23.5% 22.7% 24.3% 23.9% 24.4% 22.8% 19.8% 15.5% 14.0% 12.1% 11.6% 9.6% 7.9% 9.8% 14.2% 13.0% 14.8% 14.2% 14.19%
Internal Growth Rate 16.9% 13.7% 15.3% 16.1% 17.5% 17.3% 17.6% 18.2% 15.4% 11.8% 10.5% 9.6% 9.1% 7.3% 5.9% 7.8% 11.7% 10.2% 11.8% 11.8% 11.83%
Cash Flow Quality
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
OCF/Net Income 0.87 1.02 1.06 0.88 0.71 0.49 0.33 0.27 0.25 0.30 0.36 0.76 1.02 1.24 1.47 1.38 1.14 1.63 1.55 1.52 1.518
FCF/OCF 0.87 0.89 0.90 0.84 0.76 0.73 0.65 0.79 1.00 1.00 1.00 0.94 0.93 0.92 0.92 0.92 0.93 0.95 0.95 0.95 0.950
FCF/Net Income snapshot only 1.442
OCF/EBITDA snapshot only 1.087
CapEx/Revenue 1.5% 1.5% 1.5% 2.0% 2.4% 1.9% 1.6% 0.8% 0.0% 0.0% 0.0% 0.6% 1.1% 1.6% 2.0% 1.8% 1.4% 1.4% 1.2% 1.3% 1.27%
CapEx/Depreciation snapshot only 0.669
Accruals Ratio 0.02 -0.00 -0.01 0.02 0.05 0.08 0.11 0.11 0.10 0.07 0.06 0.03 -0.00 -0.03 -0.07 -0.05 -0.02 -0.08 -0.07 -0.07 -0.067
Sloan Accruals snapshot only 0.060
Cash Flow Adequacy snapshot only 5.981
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Dividend Yield 0.1% 0.1% 0.1% 0.1% 0.2% 0.1% 0.1% 0.0% 0.0% 0.0% 0.0% 0.4% 0.6% 0.8% 1.2% 0.9% 0.7% 0.6% 0.4% 0.5% 0.31%
Dividend/Share $0.52 $0.54 $0.55 $0.62 $0.68 $0.54 $0.40 $0.20 $0.00 $0.00 $0.00 $1.55 $3.11 $4.65 $6.20 $4.89 $3.54 $3.19 $1.86 $1.94 $1.30
Payout Ratio 6.9% 7.4% 6.8% 7.2% 7.4% 5.3% 4.0% 2.0% 0.0% 0.0% 0.0% 21.0% 35.6% 48.1% 60.1% 48.1% 31.8% 29.4% 17.5% 17.8% 17.83%
FCF Payout Ratio 9.1% 8.2% 7.2% 9.8% 13.8% 14.9% 18.6% 9.2% 0.0% 0.0% 0.0% 29.3% 37.7% 42.1% 44.7% 37.9% 30.0% 19.0% 11.8% 12.4% 12.36%
Total Payout Ratio 6.9% 7.4% 6.8% 7.2% 7.4% 5.3% 4.0% 2.0% 0.0% 0.0% 0.0% 21.0% 35.6% 48.1% 60.1% 48.1% 31.8% 29.4% 17.5% 17.8% 17.83%
Div. Increase Streak 1 1 1 1 1 0 0 0 — — — 0 0 0 0 1 1 0 0 0 0
Chowder Number 1.39 0.69 0.21 0.27 0.32 -0.01 -0.27 -0.67 — — — 6.75 — — — 2.15 0.15 -0.31 -0.70 -0.60 -0.597
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Shareholder Return 0.1% 0.1% 0.1% 0.1% 0.2% 0.1% 0.1% 0.0% 0.0% 0.0% 0.0% 0.4% 0.6% 0.8% 1.2% 0.9% 0.7% 0.6% 0.4% 0.5% 0.53%
DuPont Factors
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Tax Burden (NI/EBT) 0.76 0.76 0.76 0.74 0.74 0.74 0.75 0.77 0.76 0.76 0.76 0.73 0.74 0.74 0.74 0.74 0.74 0.75 0.75 0.75 0.746
Interest Burden (EBT/EBIT) 1.03 1.03 1.03 1.03 1.03 1.03 1.05 1.06 1.10 1.16 1.23 1.22 1.20 1.19 1.19 1.20 1.20 1.15 1.10 1.04 1.044
EBIT Margin 0.17 0.17 0.18 0.18 0.18 0.19 0.18 0.18 0.16 0.14 0.13 0.15 0.17 0.18 0.19 0.18 0.19 0.19 0.20 0.22 0.215
Asset Turnover 1.16 0.99 1.04 1.08 1.15 1.08 1.09 1.10 1.02 0.87 0.81 0.85 0.89 0.83 0.85 0.87 0.93 0.80 0.78 0.77 0.767
Equity Multiplier 1.73 1.77 1.77 1.64 1.64 1.62 1.62 1.48 1.48 1.47 1.47 1.39 1.39 1.41 1.41 1.36 1.36 1.40 1.40 1.34 1.341
Per Share
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
EPS (Diluted TTM) $7.45 $7.38 $8.06 $8.51 $9.14 $10.09 $10.10 $10.10 $8.56 $7.36 $6.67 $7.41 $8.71 $9.68 $10.32 $10.15 $11.15 $10.87 $10.64 $10.89 $10.89
Book Value/Share $30.90 $35.28 $35.24 $38.72 $38.65 $44.51 $44.40 $47.88 $47.88 $50.54 $50.78 $48.96 $48.96 $54.33 $54.30 $58.27 $58.08 $64.06 $64.06 $67.96 $67.99
Tangible Book/Share $30.69 $35.07 $35.03 $38.35 $38.28 $44.09 $43.98 $47.45 $47.45 $50.07 $50.31 $47.22 $47.21 $52.60 $52.58 $56.53 $56.35 $62.33 $62.33 $66.25 $66.25
Revenue/Share $55.72 $55.85 $58.72 $61.50 $65.47 $69.71 $70.46 $70.58 $65.33 $60.65 $56.69 $57.03 $59.32 $60.94 $62.90 $63.23 $67.39 $66.27 $64.79 $64.92 $65.01
FCF/Share $5.67 $6.66 $7.65 $6.30 $4.92 $3.61 $2.15 $2.18 $2.18 $2.19 $2.39 $5.30 $8.23 $11.06 $13.88 $12.89 $11.82 $16.77 $15.73 $15.70 $8.41
OCF/Share $6.48 $7.50 $8.52 $7.52 $6.49 $4.97 $3.28 $2.75 $2.18 $2.19 $2.39 $5.62 $8.87 $12.02 $15.15 $14.00 $12.75 $17.69 $16.48 $16.52 $8.72
Cash/Share $10.67 $15.87 $15.85 $11.56 $11.54 $14.53 $14.50 $11.33 $11.33 $28.15 $28.29 $17.87 $17.87 $26.47 $26.46 $25.29 $25.21 $22.71 $22.71 $20.21 $20.19
EBITDA/Share $10.18 $10.09 $11.06 $11.84 $12.55 $13.78 $13.60 $13.05 $10.88 $9.05 $7.93 $9.09 $10.72 $11.87 $12.65 $12.31 $13.42 $13.68 $14.14 $15.19 $15.19
Debt/Share $0.65 $0.86 $0.86 $0.76 $0.75 $0.63 $0.63 $0.68 $0.68 $0.58 $0.58 $0.61 $0.61 $0.58 $0.58 $1.04 $1.04 $1.17 $1.17 $1.27 $1.27
Net Debt/Share $-10.02 $-15.01 $-14.99 $-10.81 $-10.79 $-13.90 $-13.87 $-10.64 $-10.65 $-27.57 $-27.70 $-17.26 $-17.26 $-25.90 $-25.88 $-24.25 $-24.17 $-21.54 $-21.54 $-18.94 $-18.94
Academic Models
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 12.125
Altman Z-Prime snapshot only 22.553
Piotroski F-Score 8 7 7 7 6 7 6 7 5 5 6 5 7 7 7 6 5 7 5 5 5
Beneish M-Score -2.26 -2.18 -2.17 -2.20 -2.00 -1.53 -1.40 -1.71 -1.76 -2.65 -2.75 -2.55 -2.60 -1.74 -1.88 -1.77 -1.62 -2.63 -2.54 -2.27 -2.268
Ohlson O-Score snapshot only -12.283
ROIC (Greenblatt) snapshot only 24.17%
Net-Net WC snapshot only $45.30
EVA snapshot only $3023809907.02
Credit
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Credit Rating snapshot only AAA
Credit Score 96.06 95.78 95.72 95.82 96.14 96.61 96.45 96.24 96.60 96.58 96.79 96.95 96.68 96.59 96.44 96.29 96.44 96.36 96.56 96.59 96.586
Credit Grade snapshot only 1
Credit Trend snapshot only 0.295
Implied Spread (bps) snapshot only 50.000
Industry Credit Rank snapshot only 93
Sector Credit Rank snapshot only 94

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms